Viveve Medical Stock (NASDAQ:VIVE)
Previous Close
$NaN
52W Range
- - $0.11
50D Avg
-
200D Avg
-
Market Cap
$17.16K
Avg Vol (3M)
$1.72K
Beta
-0.72
Div Yield
-
VIVE Company Profile
Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.
VIVE Performance
Peer Comparison
Ticker | Company |
---|---|
BMRA | Biomerica, Inc. |
RPID | Rapid Micro Biosystems, Inc. |
INVO | INVO Bioscience, Inc. |
CTSO | Cytosorbents Corporation |
TIVC | Tivic Health Systems, Inc. |
NUWE | Nuwellis, Inc. |
RSLS | ReShape Lifesciences Inc. |
BBLG | Bone Biologics Corporation |
HSCS | Heart Test Laboratories, Inc. |
MOTS | Motus GI Holdings, Inc. |
HSDT | Helius Medical Technologies, Inc. |
TNON | Tenon Medical, Inc. |
SINT | Sintx Technologies, Inc. |
NAOV | NanoVibronix, Inc. |